Tidemark’s Zimmer Biomet ZBH Stock Holding History

Tidemark’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-97	Closed	-$8.83K	–	711
2025 Q2	$8.83K	Hold	97	–	–	﹤0.01%	466
2025 Q1	$10.9K	Buy	97 +1	+1%	+$107	﹤0.01%	423
2024 Q4	$10.2K	Hold	96	–	–	﹤0.01%	443
2024 Q3	$10.4K	Hold	96	–	–	﹤0.01%	428
2024 Q2	$10.4K	Hold	96	–	–	﹤0.01%	409
2024 Q1	$12.7K	Hold	96	–	–	0.01%	405
2023 Q4	$11.7K	Buy	+96	New	+$10.7K	0.01%	401

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tidemark's ZBH Position: Q3 2025 in Review

Tidemark sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 97 shares — an estimated $8.83K sold.

Tidemark first reported a position in ZBH in Q4 2023 and held it in 7 quarters. The position peaked at $12.7K in Q1 2024. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Tidemark reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Tidemark sold 97 Zimmer Biomet shares in Q3 2025, an estimated $8.83K.
Tidemark first reported a position in Zimmer Biomet in Q4 2023 and held it in 7 quarters.
Tidemark's Zimmer Biomet position peaked at $12.7K in Q1 2024.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Tidemark's 13F filing for Q3 2025, filed 3 Nov 2025.